Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by deeppocket83on Mar 22, 2017 6:19pm
260 Views
Post# 26017023

RE:Paying debt with debt , It's got that bad

RE:Paying debt with debt , It's got that badLast year their debt was 34B now its 28B after Dandreon sale goes through. Another 3 in asset sales this year plus 2B in FCF towards debt will knock this down to 23B end of year. They got a great rate to refinance and remove covenants. I guess you have no finance background. Have a nice day Joe and stay short.
<< Previous
Bullboard Posts
Next >>